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Abstract
The essential folding and maturation process of proinsulin in b-cells is largely uncharacterized. To analyze this process, we
improved approaches to immunoblotting, metabolic labeling, and data analysis used to determine the proportion of
monomers and non-monomers and changes in composition of proinsulin in cells. We found the natural occurrence of a
large proportion of proinsulin in various non-monomer states, i.e., aggregates, in normal mouse and human b-cells and a
striking increase in the proportion of proinsulin non-monomers in Ins2
+/Akita mice in response to a mutation (C96Y) in the
insulin 2 (Ins2) gene. Proinsulin emerges in monomer and abundant dual-fate non-monomer states during nascent protein
synthesis and shows heavy and preferential ATP/redox-sensitive disposal among secretory proteins during early post-
translational processes. These findings support the preservation of proinsulin’s aggregation-prone nature and low relative
folding rate that permits the plentiful production of non-monomer forms with incomplete folding. Thus, in normal mouse/
human b-cells, proinsulin’s integrated maturation and degradation processes maintain a balance of natively and non-
natively folded states, i.e., proinsulin homeostasis (PIHO). Further analysis discovered the high susceptibility of PIHO to
cellular energy and calcium changes, endoplasmic reticulum (ER) and reductive/oxidative stress, and insults by thiol reagent
and cytokine. These results expose a direct correlation between various extra-/intracellular influences and (a)typical
integrations of proinsulin maturation and disposal processes. Overall, our findings demonstrated that the control of
precursor maturation and disposal acts as an early regulative mechanism in normal insulin production, and its disorder is
crucially linked to b-cell failure and diabetes pathogenesis.
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Introduction
Pancreatic b-cell failure, which is central in the pathogenesis of
diabetes, has been explained by autoimmune assault in type 1
diabetes (T1D) [1] and by glucolipotoxicity, amyloid deposition,
insulin resistance, unfolded protein response (UPR), and
endoplasmic reticular (ER) and/or oxidative stress in type 2
diabetes (T2D) [2–14]. However, it remains unclear whether
there is an intrinsic process that is susceptible to these diabetes-
related influences and linked as well to b-cell dysfunction in all
forms of diabetes. Among monogenic disorders, early studies
characterized syndromes similar to T2D that were caused by
mutations in the insulin (INS) gene in non-neonatal patients [15].
In Akita mice, we identified a mutation (Ins2
+/Akita, C96Y) that
did not remarkably attenuate synthesis (at early ages) but that did
cause abnormal aggregation and degradation of cellular (pro)in-
sulin [16], which, in turn, produced numerous intracellular toxic
consequences, abnormalities in insulin secretion, b-cell depletion,
and early onset diabetes [16–18]. Similar pathogenesis is
implicated in up to 20% of neonatal diabetes that associates
with defects in the INS gene and with proband variants for T1D,
maturity onset diabetes of the young, and even T2D [19,20].
Those subjects with defects in the same preproinsulin molecule
showed similar b-cell failure as that seen in general diabetes, such
as hyper- or hypo(pro)insulinemia. Therefore, we suggest that the
misfolding and impaired maturation of proinsulin is linked to b-
cell failure in all diabetics.
Proinsulin is the dominant form of insulin in the early
secretory pathway following the rapid removal of signal peptide
from preproinsulin and conversion of the natively folded
proinsulin into mature insulin [15]. Insulin is the most abundant
protein product of b-cells and constitutes up to 14% of the dry
weight of rodent islets/b-cells [21,22]. Studies of protein
biosynthesis in rodent/carp islets have shown incorporation of
6 to 30% of radioactive amino acids into preproinsulin in basal
or glucose-stimulated conditions [23,24], although islets/b-cells
produce more than 20,000 proteins. Thus, proinsulin bears the
greatest burden in b-cell protein folding. Since the discovery of
proinsulin in 1967 [25], metabolic-labeling studies have
consistently demonstrated the rapid appearance of monomers
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e19446in the ER supports the long-held belief that proinsulin rapidly
achieves its native conformation [15]. As well, Huang and Arvan
[26] have indicated that intracellular disulfide bonds form
quickly in most proinsulin monomers and exit the ER in about
20 minutes.
However, the folding rate of cellular proinsulin has not been
determined. In this study, we define a relative folding rate as the
percentage of natively folded proinsulin monomers in a given
period in all synthesized proinsulin polypeptides. These polypep-
tides include proinsulin monomers and all other non-natively
(incompletely/incorrectly) folded proinsulin aggregates other than
monomer states (non-monomers). With a rate of proinsulin folding
well below 100%, the natural instability of the non-natively folded
polypeptides would contribute to the appearance of a fraction of
non-natively folded proinsulin in b-cells with possible aggregation
for further maturation or clearance. We previously noted
remarkable proinsulin aggregation in normal islets in Akita mice
with significantly increased proinsulin aggregates resulting from an
Ins2
+/Akita mutation. However, we chose not to examine proinsulin
aggregation in normal b-cells in that study [16,17], partly because
the states of endogenous proinsulin have not been demonstrated
despite satisfactory documentation of labeled nascent proinsulin
monomers by many pulse-chase studies and because no well
developed immunoblotting approaches have been employed in
(pro)insulin study, though such approaches have been applied
extensively in determining numerous protein states/levels. Im-
proved approaches are required for better visualization of the
states/bands of immunoreactive (pro)insulin in whole-cell protein
pools in the study of b-cell biology. Moreover, despite much
progress in biomedical studies, methods for analyzing protein
folding in vivo remain suboptimal [27] and prevent our discerning
the entire mechanism of proinsulin maturation and its link with b-
cell (dys)function.
We have used our improved approaches to metabolic labeling
and C-peptide immunoblotting to visualize proinsulin aggregates
in normal islets [16,17] and applied them in this study to
determine the natural occurrence of a significant proportion of
proinsulin in normal b-cells as various non-monomer states. We
could ascertain that the aggregation-prone nature and very low
relative folding rate of proinsulin maintains a balance of non-
natively and natively folded states through the integration of
maturation and degradation processes in normal b-cells and that
PIHO is highly susceptible to various extra-/intracellular influ-
ences. Our findings demonstrated that the process of proinsulin
maturation determines the rate and efficiency of insulin biosyn-
thesis and led us to hypothesize a model of PIHO in b-cell
(dys)function.
Results
A significant fraction of proinsulin exists in non-
monomer states in the whole-cell protein pool of b-cells
in normal mice
For immunoblot analysis, we extracted whole-cell proteins from
mouse islets in a radioimmunoprecipitation assay (RIPA) buffer
[16] using sample preparation procedure A (SPP-A) (detailed in
‘‘Materials and Methods’’). In collecting protein samples in all
studies described, we included 20 mM of N-ethylmaleimide to
block free thiols. C-peptide immunoblot analysis detected various
non-monomer and 2-monomer states of proinsulin under non-
reduced condition in normal Ins2
+/+ islets (Fig. 1A; Figure S1A
shows their molecular weights calculated). Consistent with our
previous work [16], we added dithiothreitol (DTT) to create a
reduced condition and thereby observed significant disappearance
of the signal of non-monomer states with simultaneous enhance-
ment of the signal of proinsulin monomers (Fig. 1A). However, we
observed some DTT-resistant signals in non-monomer areas in
images with long exposures (data not shown). We considered that
monomer a likely represented the proinsulin with native
conformation because of its general preponderance in normal
islets (Fig. 1A) and cloned mouse b-cells (Fig. S1B) and its
migration pattern that resembled that of human proinsulin
markers (unpublished observation). As observed in metabolic-
labeling studies, form b may be an isomer [28] because its
abundance was secondary in normal islets but richer in the Ins2
+/
Akita islets under non-reduced condition. Form b may also be a
mixture of the same isomers observed on high concentration
tricine sodium dodecyl sulfate polyacrylamide gel electrophoresis
(SDS-PAGE) with urea [28] (unpublished observation); resolution
of the applied tricine SDS-PAGE without urea was limited.
Variation in control of tubulin was not as great as that of
proinsulin. Consistent with previous observations [16,26], proin-
sulin monomers also migrated slightly slower on the tricine gel
under reduced than non-reduced condition in most cases (Figs. 1,
2, 3, 4, 5, 6).
Quantitative analysis (detailed in ‘‘Materials and Methods’’)
revealed that the immunoreactivity of the non-monomer states
represented most of the total C-peptide immunoreactivity in the
mutant islets, and represented a significant fraction of the total C-
peptide immunoreactivity in normal islets under non-reduced
condition (Figs. 1A–1D; Tables S1, S2, S3). Among the diverse
non-monomer states, those in Areas A to C were richer in normal
islets, but those with high molecular weights in Areas D to F were
more abundant as severe aggregates in the mutant, regardless of
their currently unknown natures (Fig. 1A, B). The much higher
level of proinsulin in normal islets than in the mutant (Fig. 1A)
precludes a causal link in the whole-cell protein pools between the
level of proinsulin and the proportion of proinsulin non-
monomers. Together, the above observations suggest a distur-
bance in the normal balance of proinsulin monomer and abundant
non-monomer states in the mutant islets.
We also determined whether the pattern of proinsulin states
can be preserved in early cloned MIN6 b-cells and recently
established Ins2
+/+ and Ins2
+/Akita b-cells [18]. C-peptide
immunoblot analysis showed a similar pattern of proinsulin states
in MIN6 and Ins2
+/+ b-cells to that in normal islets, whereas the
pattern in Ins2
+/Akita b-cells resembled that in mutant islets
(Fig. 1A, S1B). Differences in the applied gels and protein extract
buffers (detailed in ‘‘Materials and Methods’’) as well as possible
variations between islets and cloned b-cells could produce slight
discrepancies in migration or density of some states. Similarly,
monomer b detected in immunoblotting (Fig. 1A, 16.5% tricine
gel) did not appear in most autoradiographs (Figs. 2A, 3A, 4A,
10% tricine gel), though it was visible in the image with longer
electrophoresis (Fig. 5A).
A significant fraction of proinsulin emerges in non-
monomer states during nascent protein synthesis in
normal mouse/human b-cells
To investigate the basis for the occurrence of proinsulin non-
monomer states, we used basically the same labeling and
immunoprecipitation (IP) method applied by Steiner’s group
[29] and examined whether non-monomers appear quickly during
de novo proinsulin synthesis. The radioautograph shows approxi-
mately 58% monomers and 42% non-monomers precipitated by
insulin IP and about 40% monomers and 60% non-monomers
recovered by C-peptide IP from islet proteins labeled 30 minutes
with
35S-methionine (Met) (Fig. 2A, B; Table S4). (Applying
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dominant proinsulin 2 form and not in proinsulin 1 in mice). The
data indicate that nascent proinsulin non-monomers shape quickly
and have lower affinity with the high conformation-dependent
insulin antisera [30] than with C-peptide antisera. Therefore,
recovery of the proinsulin non-monomers by IP using only insulin
antisera is relatively limited because of the well known high
dependence of insulin antisera on conformation, which requires
the natively folded proinsulin to generate specific recognition
epitope(s) [30]. On the other hand, C-peptide antisera react with
an unstructured peptide whether free or within the proinsulin
molecule. These properties enhance detection of non-natively
folded proinsulin molecules by C-peptide antisera regardless of
their state in processes. We also found that approximately 34%
nascent proinsulin non-monomers appeared in 30-minute labeled
human islets (Fig. 2E, F; Table S6), and that the completely folded
125I-proinsulin marker (Linco) in islet protein extracts that was
subjected to the same IP and electrophoresis procedure did not
form significant aggregates (Fig. S2, Table S7). Moreover, the
proinsulin states of Ins2
+/Akita islets (Fig. 1) were similarly disturbed
during nascent protein synthesis (Fig. 2C, D; Table S5). These
data suggest that the proinsulin non-monomer states of islets/b-
cells are primarily shaped in vivo prior to protein extractions and
result mainly from non-natively folded proinsulin.
Proinsulin maintains a significant proportion of non-
monomer states in the homeostasis of secretory proteins
in an extended de novo synthesis course
Because islets of various sizes have different b-cell numbers and
MIN6 b-cells are known to preserve the basic characteristics of
their pancreatic b-cell progenitors, we further investigated the
basic properties of endogenous proinsulin states in MIN6 b-cells.
We found a gradual increase in the proportion of islet amyloid
polypeptide precursor (pro-IAPP) monomers from 77 to 88% from
5 to 30 minutes during a pulse course. Strikingly, the proportion of
35S-proinsulin monomers increased from 41 to 49% in C-peptide
immunoprecipitates and from 64 to 76% in insulin immunopre-
cipitates (Fig. 3A–D; Tables S8, S9). Just as in whole-cell protein
pools (Fig. 1), we found no causal link between the level of
proinsulin and the proportion of proinsulin non-monomers in
nascent protein pools; we did observe an anti-parallel relationship
between the
35S-proinsulin/
35S-pro-IAPP level and non-monomer
proportion during this synthesis course. Prohormone convertase
1/3 (PC1/3), another internal control, reached up to 85% in a 3-
minute chase after a 5-minute pulse (Fig. 4D, E). These data
indicate that proinsulin maintains most abundant non-monomer
states among these nascent secretory proteins, though all these
proteins must form intramolecular disulfide bonds in the ER and
are targeted for insulin granules following synthesis.
Figure 1. A significant fraction of proinsulin exists in non-monomer states in the whole-cell protein pool of normal mouse islets. (A).
Equal amounts (30 mg) of Ins2
+/+ and Ins2
+/Akita islet proteins in the RIPA buffer were resolved by reduced (100 mM DTT) and non-reduced tricine-SDS-
PAGE (16.5%T, 6% C; without urea) and then subjected to C-peptide immunoblot analysis. M, male; F, female. (B) Percentage of each state in (A). (C)
The relative levels of proinsulin monomers under the 2 conditions in (A). (D) The proportions of proinsulin monomers and non-monomers in the
normal and mutant islets in (A) that were calculated by using the method introduced in ‘‘Materials and Methods.’’ The data in (C) and (D) were
reported as mean 6 SD. *P,0.05; **P,0.005.
doi:10.1371/journal.pone.0019446.g001
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natively folded, and those of monomers are natively folded [27,31]
irrespective of inclusion of possible isomers. Therefore, the high
percentage of proinsulin non-monomers that constantly appeared
among normal islet/b-cell proteins (Figs. 1, 2, 3, 4, 5, 6) indicates a
low relative folding rate of proinsulin. Moreover, comparison of
about 10 islet proteins (Fig. S3) demonstrates that the folding rate
of proinsulin is the lowest known.
Heavy and preferential ATP/redox-sensitive disposal and
non-monomer dual fate of nascent proinsulin during the
early post-translational process
After a 5-minute pulse, MIN6 b-cells were chased at 3, 6, 12,
and 12 minutes with antimycin (10 mM), DTT (5 mM), or
oxidized glutathione (GSSG; 50 mM). From the 3- to 12-minute
natural chase, the fraction of proinsulin monomers increased
steadily from 46 to 53%, or the fraction of control PC1/3
monomers increased from 85 to 90% (Fig. 4A, B, D, E; Tables
S10, S11). Folding efficiency increased slightly from the 3- to 12-
minute chase by removal of more non-monomers than monomers,
and as the monomer and non-monomer proportions fluctuated,
the level of
35S-proinsulin decreased 7% (Fig. 4A, C; Table S12).
The decrease was not due to conversion of
35S-proinsulin into
insulin because this customary route for nascent proinsulin is
inactive during this limited chase course [15,26]. Among the
various 12-minute chases, the monomer fractions of nascent PC1/
3 changed slightly (,15%) (Fig. 4D, E; Table S11), but those of
proinsulin changed radically. Compared to about 53% at the 12-
minute natural chase or with addition of GSSG, the fraction
decreased to 17% with antimycin treatment, which resulted from
the blocking of the in vivo conversion of proinsulin non-monomers
to monomers and from the blocking of the heavy removal of
proinsulin non-monomers (Fig. 4A, B; Table S10). In contrast,
adding DTT during the 12-minute chase increased the
35S-
proinsulin monomer fraction to 80%, mainly from the in vivo
conversion of most non-monomers to monomers.
Unexpectedly, comparisons of the natural 3- to 12-minute
chases to the 12-minute chases with addition of antimycin or DTT
disclosed an additional bulk removal of
35S-proinsulin in the
MIN6 cells. The level of
35S-proinsulin plateaued with DTT
treatment rather than in the expected 3-minute chase, which was
the shortest chase after the 5-minute pulse (Fig. 4A, C; Table S12).
Compared to the plateau (100%), around 74% of proinsulin was
retained with antimycin treatment, 35 to 36% in the 3- or 6-
minute chase, and 27 to 29% in the 12-minute chase with or
without GSSG. These data indicate that over 60% of
35S-
proinsulin was removed within a limited time in the post-
translational processing. In contrast, PC1/3 levels varied less than
15% among the diverse chases (Fig. 4D, F; Table S13). A latent
but powerful substrate-selective disposal process, termed ‘‘rapid
disposal’’ (RD), has thus been found in the early post-translational
processing of proinsulin.
Addition of DTT reduced the disulfide bonds of proinsulin in vivo
in a process reflected by a slightly slower migration of proinsulin
monomers on the gel (Fig. 4A), which consistently indicated that
proinsulin per se is sensitive to DTT before it exits the ER [26].
Figure 2. A significant proportion of nascent proinsulin emerges in non-monomer states during nascent protein synthesis in mouse
and human islets. Labeled mouse (A and C) or human (E) islet proteins were subjected to IP as indicated in A, C, and E. Equal amounts of individual
immunoprecipitates were resolved by non-reduced and reduced tricine-SDS-PAGE for autoradiography. Proinsulin monomer and non-monomer
proportions in individual immunoprecipitates in A, C, and E that were calculated using the method introduced in ‘‘Materials and Methods’’ were
shown in B (A), D (C), and F (E). Note the image in (C) is the radioautograph of a membrane prepared by the same procedure for immunoblotting
(Fig. 1A), and the slightly unusual position of proinsulin monomers at reduced versus non-reduced condition in (C) resulted from a margin effect of
electrophoresis. In addition, adherence of small polypeptides to the membrane in (C) at protein transfer reduced the transfer efficiency of large
proteins. As a consequence, the signal of proinsulin non-monomer states under non-reduced condition or of unidentified molecular helpers (e.g.,
possible protein disulfide isomerases) under reduced condition (apparent in the upper area of the membrane) was weaker than the original
radioactivity (Fig. 2A, C). Arrows in (F), proinsulin monomers; Cp, C-peptide; Ins, insulin; IP, immunoprecipitation. Data in (B), (D), and (E) were reported
as mean 6 SD. **P,0.005.
doi:10.1371/journal.pone.0019446.g002
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monomer dissociation with unidentified DTT-sensitive molecular
helpers (e.g., possible protein disulfide isomerases) that were shown
in the upper area of reduced gels (Figs. 2, 3, 4, 5). As demonstrated
in the immunoblot analysis (Fig. 1), we cannot exclude DTT-
resistant states that may represent forms of proinsulin modified by
non-disulfide bonds that still migrate to the upper area of the
reduced gel. The addition of DTT here facilitated comparisons
among these chases by providing a
35S-proinsulin pool, a significant
fraction of which escaped clearance.
Antimycin, an inhibitor of ATP production and inducer of
reactive oxygen species (ROS) in mitochondria [32], significantly
suppressed proinsulin removal by uncharacterized mechanisms.
Against the plateau in the DTT chase, about three-fourths of the
proinsulin, mainly non-monomers and mostly naturally cleared,
was retained with the addition of antimycin, whereas only about a
third was retained in all other chases. The biggest ratio of non-
monomers to monomers, noted as well in the antimycin chase,
indicated that the addition of antimycin inhibited the conversion
of proinsulin non-monomers to monomers in the maturation
process (Fig. 4A, B; Table S10). Comparison of proinsulin
monomer levels in the 12-minute chases with and without
antimycin on non-reduced gel indicated maturation of over 20%
of proinsulin monomers in this way (Fig. 4A). Concomitantly, a
large fraction of proinsulin non-monomers that escaped from the
antimycin block became monomers that could be processed
energy independently or by utilizing the ATP present in cells.
Overall, a clearance route has been revealed in the early post-
translational processing of proinsulin that is characterized by
marked ATP/redox sensitivity (yin) counterbalanced by a matura-
tion route that is partially dependent upon ATP (yang). The
inhibition of proinsulin maturation, degradation, and movement
herein exposed may be affected by energy poisons, such as
antimycin, that influence proinsulin transport, a process observed
in early indirect examinations [33,34]. Moreover, a dual fate of
proinsulin non-monomers for the yin-yang routes is revealed.
Prolonged residual non-monomer fraction and rapid
disposal (RD) of nascent proinsulin in the post-
translational process
To ascertain how fast the abundant nascent proinsulin non-
monomers disappear, we analyzed proinsulin kinetics in MIN6 b-
cells chased at 3, 30, 60, and 60 minutes with antimycin after a
Figure 3. Proinsulin maintains a significant proportion of non-monomer states in the homeostasis of secretory proteins in an
extended de novo synthesis course. MIN6 b-cells were labeled for 5, 15, and 30 minutes at the 25.5 mM glucose condition, and cellular proteins
were then subjected to serial IP with insulin (Ins), C-peptide (Cp), or IAPP antisera. Equal amounts of Ins, Cp, or IAPP immunoprecipitates were
resolved by 10% non-reduced and reduced tricine-SDS-PAGE for autoradiography. The monomer and non-monomer proportions of proinsulin in Ins
or Cp immunoprecipitates (A) or pro-IAPP in IAPP immunoprecipitates (C) that were calculated using the method introduced in ‘‘Materials and
Methods’’ were shown in B (A) and D (C). P5, 5-min pulse; P15, 15-min pulse; P30; 30-min pulse. Data in (B) and (D) were reported as mean 6 SD.
**P,0.005.
doi:10.1371/journal.pone.0019446.g003
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of proinsulin monomers in C-peptide immunoprecipitates in-
creased from 54 to 83% (Fig. 5A, B; Table S14). However, this
83% can only be compared with the proportion of PC1/3 or pro-
IAPP monomers at completion of 5- or 15-minute de novo synthesis
(Figs. 3D, 4E; Tables S9, S11). Seventeen percent of nascent
proinsulin is still in non-monomer states after a 75-minute course,
during which regulated secretory proteins normally should already
have been located in the immature secretory granules after a long
trip through the ER, Golgi, and trans-Golgi network [15].
Proinsulin non-monomers showed a longer half-life than the
control proteins in b-cells. Likewise, when pH in a test tube is
neutral, proinsulin is prone to form amorphous precipitates and is
less stable than insulin, and its unidentified intermediate folding
states are suggested in in vitro studies outside the cell without the
assistance of molecular chaperones [35,36]. In a recent study, the
property of matured insulin to unfold and oligomerize has been
harnessed to achieve a glucose regulatory effort for treatment of
diabetes in rodent models [37]. Thus, the long half-life could be
linked to the primary amino acid sequence in addition to
intracellular environments and may be physiologically required
to facilitate processes and their regulation, such as the maturation,
disposal, and (retro)transport in the quality control of the early
secretory pathway [38]. As well, the gradually decreased
proportion of non-monomers and gradually increased proportion
of monomers in proinsulin composition during the 12- and 60-
minute chases (Figs. 4,5) further showed the preferential processing
of non-monomers during early post-translational processing.
Figure 4. Nascent proinsulin kinetics in states and levels during early post-translational processing. MIN6 b-cells were chased for the
indicated times with/without antimycin (10 uM), DTT (5 mM), or GSSG (50 uM) after a 5-min pulse, and cellular proteins were then subjected to serial
IP with insulin (Ins) and C-peptide (Cp) antisera or PC1/3 antisera. Equal amounts of Ins and Cp immunoprecipitates (A) or PC1/3 immunoprecipitates
(D) were respectively resolved by 10% tricine or 7.5% Laemmli non-reduced and reduced SDS-PAGE for autoradiography. The monomer and non-
monomer proportions of proinsulin or PC1/3 in individual immunoprecipitates that were calculated using the method introduced in ‘‘Materials and
Methods’’ were shown in B (A) and E (D). Relative levels of nascent proinsulin monomers in (A) or PC1/3 monomers in (D) of individual
immunoprecipitates (on the reduced gel) were shown in C (A) and F (D). Empty arrow in (D), possible PC1/3 precursor. Data in (B), (C), (E), and (F) were
reported as mean 6 SD. *P,0.05; **P,0.005.
doi:10.1371/journal.pone.0019446.g004
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35S-proinsulin plateau retained in the 60-
minute chase with antimycin, up to 22% of
35S-proinsulin
disappeared after the 3-minute chase; 52%, after the 30-minute
chase; and 75%, after the 60-minute chase (Fig. 5A, C; Table S15).
This result further supports the role of the disposal route in early
proinsulin post-translational processing because numerous studies
indicate that processing into insulin alone cannot fully explain such
a significant drop in 60 minutes during the general 2-hour course
of conversion [15]. As shown in the 12-minute chase (Fig. 4),
10 mM of antimycin cannot completely block proinsulin removal,
and more proinsulin could actually be removed than our evidence
shows. Even so, we validated removal of at least 20% of proinsulin
by the mechanism of RD in these 2 chase courses (Figs. 4, 5)
regardless of the different pulse times. Additionally, the inhibitive
effect of antimycin shown in these 2 chase courses suggests a role
of the mitochondria in proinsulin maturation and disposal, which
provides new insights into the link between mitochondria and
insulin secretion previously reviewed [39].
In eukaryotic cells, the lysosomal (autophagy) and proteasomal
pathways are the 2 main routes by which cellular proteins are
cleared. Up to 30% of nascent proteins are thought to be defective
ribosomal products and can be rapidly degraded by proteasomes
[40]. Under stress, a fraction of some secretory proteins can be
removed by proteasomes in cytosol resulting from failure in
passage of the ER translocon [41,42] or by autophagy and ER-
associated degradation after entry into the ER lumen [38,43,44].
It is unclear in proinsulin clearance whether RD is a completely
novel process or an element of these revealed mechanisms, but
there is no doubt that rapid clearance plays an active role in
removing endogenous proinsulin in b-cells.
Susceptibility of proinsulin maturation process to extra-/
intracellular influences
The above study revealed the low relative folding rate/efficiency
of proinsulin that underlies the susceptibility of proinsulin
maturation to the influence of genetic disorder, DTT, antimycin,
and other possible factors. To identify potential factors, we
examined the effects of various reagents on proinsulin maturation.
During a 60-minute post-translational process in which MIN6 b-
cells were exposed to cycloheximide (Chx; 100 mg/mL, a protein
Figure 5. Prolonged residual non-monomer fraction and rapid disposal of nascent proinsulin in the post-translational process. MIN6
b-cells were chased for the indicated times with/without antimycin (10 uM) after a 15-min pulse, and cellular proteins were then subjected to IP with
C-peptide (Cp) antisera. Equal amounts of individual Cp immunoprecipitates were resolved by 10% non-reduced and reduced tricine-SDS-PAGE for
autoradiography (A). Graph (B) showed the proportions of proinsulin monomers and non-monomers in individual Cp immunoprecipitates that were
calculated using the method introduced in ‘‘Materials and Methods.’’ Graph C showed the relative levels of nascent proinsulin monomers (on reduced
gel) in individual Cp immunoprecipitates in (A). Data in (B) and (C) were reported as mean 6 SD. *P,0.05; **P,0.005.
doi:10.1371/journal.pone.0019446.g005
Figure 6. Effects of various reagents on proinsulin states
during a 60-min post-translational process. We incubated MIN6
b-cells in culture medium with/without the following reagents for
60 minutes: cycloheximide (Chx; 100 mg/mL); Chx and TNFa (2 ng/mL);
tunicamycin (Tu, 1 ug/mL); thapsigargin (Tha, 2 uM); verapamil (V,
100 uM); nickel chloride (Ni, 1 mM); iodoacetamide (I, 1 mM); or H2O2
(250 uM). Cellular proteins were extracted in the tricine sample buffer
(Bio-Rad) by SPP-B, resolved by tricine-SDS-PAGE without urea (16.5%T,
5% C), and then subjected to C-peptide and tubulin immunoblot
analysis. Protein, 30 mg per lane.
doi:10.1371/journal.pone.0019446.g006
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states using C-peptide immunoblot. Results showed that compared
with the untreated control, MIN6 b-cells treated with only Chx
demonstrated significant disappearance of proinsulin (Fig. 6, Lane
2 versus Lane 1), indicating that the 60-minute inhibition of
protein synthesis with Chx enabled processing (via disposal and
maturation routes) of most proinsulin that was synthesized prior to
the addition of the Chx. In contrast, proinsulin disappeared much
more slowly when treatment with Chx was combined with tumor
necrosis factor alpha (TNFa, 2 ng/mL), tunicamycin (1 ug/mL),
thapsigargin (2 uM), verapamil (100 uM), nickel chloride (1 mM),
iodoacetamide (1 mM), or hydrogen peroxide (H2O2, 250 uM)
(Fig. 6, Lanes 3 to 9 versus Lane 2). The deceleration in protein
maturation and disposal was marked by the accumulation of more
non-monomers than monomers in most of these treatments. The
predominant accumulation of non-monomers, shown earlier in the
Ins2
+/Akita islets and the antimycin treatment (Figs. 1, 2, 4, 5), was
also noticeably induced by TNFa, thapsigargin, iodoacetamide, or
H2O2 (Fig. 6). The less potent induction by tunicamycin most
likely results from absence of the targeted process, N-linked
glycosylation, in proinsulin maturation. The weak effect of nickel
chloride demonstrated the seemingly insignificant role of the T-
type calcium channel, the target of nickel chloride, in proinsulin
maturation, although the channel may facilitate insulin secretion
[45].
TNFa, a proinflammatory cytokine, has been implicated in the
b-cell failure of T1D and T2D [46]. For instance, by reducing the
glucose-stimulated influx of Ca
2+, TNFa induced the impairment
of glucose-stimulated insulin secretion (GSIS) [46–49] but did not
affect insulin transcription [48]. Thapsigargin, an inhibitor of ER
Ca
2+ ATPase that induces UPR and ER stress by altering cytosolic
and ER Ca
2+ concentrations, can attenuate basal insulin release
and GSIS [46,50,51]. Verapamil blocks the L-type calcium
channel, the major subtype of calcium channels in b-cells
[46,52]; iodoacetamide can interfere with disulfide bond forma-
tion, a critical step in oxidative protein folding that generates ROS
by-products [53,54]; and H2O2, a highly reactive ROS that is
enriched in normal b-cells (due partly to low levels of antioxidant
enzymes), can impair cytosolic calcium handling [55]. Though the
capacity of all these reagents to attenuate basal insulin release
and/or 2-phase GSIS is known [13,45–52,54–56], we believe our
study is the first that directly correlates these reagent-targeted
molecules/pathways and the proinsulin maturation process. Such
relationship would underlie the known negative effects on b-cells
and especially serve as a basis for the vague mechanisms that
underlie the affected second phase of GSIS. In addition, our
preliminary studies have also indicated a role of glucolipotoxicity
in T2D [2,3,8–10,12–14] that affects PIHO (data not shown).
Discussion
Improved methodology enables determination of large
fractional non-monomer states and low relative folding
rate of proinsulin in normal b-cells
Proinsulin is the most abundant insulin precursor made in b-
cells. The processing of proinsulin molecules involves a complex
process of ‘‘folding.’’ Until recently, this was felt to occur very
rapidly, resulting in formation of mature insulin molecules. In this
study, we applied a number of protein extraction buffers, SPPs,
antibodies, internal controls, reagents, and analytical principles
(described in ‘‘Materials and Methods’’) to improve C-peptide
immunoblotting and pulse-chase approaches for analysis of
cellular proinsulin states. Our use of the improved approaches
allowed us to assess the fraction and folding nature of proinsulin
monomers and non-monomers in islet/b-cell nascent or whole-cell
protein pools. The results demonstrate that proinsulin preserves an
aggregation-prone nature and a low relative folding rate that result
in production of abundant non-natively folded non-monomer (i.e.,
aggregate) forms in normal mouse/human b-cells (Figs. 1, 2, 3, S1,
S2, S3). The improved approaches will help further understanding
of the folding and linked processes of cellular proinsulin and other
proteins.
Of note, the non-natively folded proinsulin non-monomers
showed lower affinity with the high conformation-dependent
insulin antisera [30] than with C-peptide antisera (Figs. 2A, 2B,
3A, 3B). These results suggest that application of C-peptide
antisera would be indeed helpful for adequate recovery/detection
of proinsulin polypeptides including the non-natively folded forms
in the study of proinsulin folding and related b-cell biology,
although the insulin antisera are being used extensively in these
aspects in current studies.
Proinsulin maintains a homeostatic balance of non-
natively and natively folded states in normal b-cells
Proinsulin is proven to be inherent with an aggregation-prone
nature and a low relative folding rate but it is the most abundant
insulin precursor made in the pancreatic b-cells [22–24]. So how
does the b-cell normally control proinsulin early post-translational
processing? The results of our pulse-chase studies indicate that the
preferential removal of dual fate non-natively folded non-
monomers of proinsulin serves as an adaptive mechanism for
flow control of secretory proteins. Proinsulin thus maintains a
homeostatic balance of natively and non-natively folded states (i.e.,
proinsulin homeostasis, PIHO) in normal b-cells as a result of the
integration of disposal and maturation processes (Figs. 4,5).
Interestingly, we found the greater abundance of unidentified
molecular helpers in the non-monomer states of nascent proinsulin
than in pro-IAPP and PC1/3 non-monomer states (as a larger ratio
of upper-area signal to proinsulin monomer signal in insulin and C-
peptide immunoprecipitates on reduced gels) (Figs. 3, 4). These
observations show the recovery of varied levels of molecular helpers
of diverse composition in the immunoprecipitates of different
nascent secretory proteins. These observations also support a recent
notion that the folding of diverse secretory proteins is assisted by
‘‘public’’ and ‘‘private’’ chaperones that are enriched in specialized
subregions to ensure the efficiency and fidelity of protein folding
[38]. In proinsulin non-monomer states, such chaperones seem to
be remarkably enriched despite the fact that chaperones of the
folding and/or degradation machineries are mostly shared by
diverse substrates. In addition, variations in the levels and/or
composition of molecular helpers between normal and Ins2
+/Akita
islets(Fig. 2C)suggest that thosedifferencescould serve asa rheostat
to influence proinsulin maturation, disposal, and flow in the early
secretory pathway of (ab)normal b-cells. Collectively, these
observations demonstrate that the control of precursor maturation
and disposal is an early regulative mechanism in the normal insulin
production of b-cells. In this context, molecular helpers located in
the non-monomer states of proinsulin may facilitate regulations of
the maturation and disposal of insulin precursor.
The link between b-cell (dys)function, diabetes, and PIHO
The relative slow completed folding process of proinsulin, which
is exposed in this study, provides not only a site for early
regulations in the normal insulin biosynthesis but also a basis for
the susceptibility of PIHO to various stresses. As shown in our
immunoblotting and pulse- chase studies (Figs. 1, 4, 5, 6), PIHO
disorders were induced by the Ins2
+/Akita genetic defect, cellular
energy and calcium changes, ER and reductive or oxidative stress,
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associated with diabetes [1–15,39,45,46]. Moreover, we have
recently found that PIHO disorders occur also in non-obese
diabetic (NOD) and db/db mice (unpublished data) that are
typical models representing for the main forms of diabetes in
humans. Our recent studies have also revealed that the primarily
disturbed PIHO results in a number of toxic consequences with
known association to b-cell failure in general forms of diabetes.
These include the atypical proinsulin disposal and processing, ER
and oxidative stress, mitochondrial abnormalities, and b-cell
depletion [16,17] (unpublished observations).
All these findings help us understand why proinsulin is an
important molecule linked to b-cell dysfunction in addition to
being the natural precursor to insulin. Based on our accumulated
evidence, we hypothesized a model that PIHO, an essential post-
translational regulation mechanism in insulin biosynthesis, may
critically link to diabetes (Fig. 7). We propose that the early control
of precursor maturation and disposal is an essential mechanism in
controlling insulin production and secretion in normal b-cells
(Fig. 7A). Consequently, the imbalance of proinsulin maturation
and disposal (induced by various factors) results in a number of
consequences that contribute to the development of b-cell failure
and diabetes (Fig. 7B).
In this study, we establish an approach for assessing proinsulin
maturation and disposal in cells that disclosed some fundamental
features of proinsulin folding and the direct correlation among
various diabetes-related risk factors. However, the molecular
mechanisms remain unclear. Further investigations are underway.
This study also provides the first experimental evidence for
hypothesizing polypeptide homeostasis in normal cells (PHIC).
Under certain conditions, molecular interactions in biological
processes reveal PHIC with detectable (non-)natively folded
protein states, such as those states in this study. Perturbations of
PHIC result in various diseases associated with atypical protein
folding, disposal, and toxic consequences [6,10,27,31]. The use of
PHIC to determine (im)balances of natively and non-natively
folded states of disease-associated proteins, such as molecules with
low folding rate or fibrillation-prone nature, will help identify true
biological defects under pathological conditions that could result in
improved interventions and treatments.
Materials and Methods
For further details, please see our Text S1 Supplemental
Experimental Procedures, which are published as Supplemental
Data on the PLoS ONE web site.
Ethics statement
All animal and tissue sample experiments were performed in
accordance with the guidelines of the National Institutes of Health
and The Ohio State University with procedures (2007A0040 and
2010A0024) approved by the Institutional Animal Care and Use
Committee (IACUC) of the university.
Materials
We obtained antibodies, chemicals, mice, and human islets from
companies and other investigators, which are detailed in the Text
S1 Supplemental Experimental Procedures.
Figure 7. Perturbation of PIHO contributes to b-cell failure and diabetes. (A) Proinsulin maintains a homeostatic balance of natively and
non-natively folded states (i.e., proinsulin homeostasis, PIHO) in normal b-cells as a result of the integration of maturation and degradation processes.
Normal b-cells can control insulin production by early regulations of its precursor maturation and disposal in response to extra- and intracellular
influences. Molecular helpers located in non-monomer states facilitate proinsulin maturation and/or disposal. (B) Based on our recent studies, we
have suggested that the perturbation of PIHO is an early defect of diabetes induced by varied factors. Over time, vicious cycles of the PIHO disorders
and linked pathways and/or compartments would be established that could contribute to the development of b-cell damage and diabetes. Yellow
indicates possible abnormalities. Left-to-right or up-and-down arrows show possible 2-way alterations/influences. Mito, mitochondria.
doi:10.1371/journal.pone.0019446.g007
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Unless specifically stated, we conducted all operations and
maintained all materials away from reducing reagents. Islet
isolation and islet and cell line culture were described previously
[16,18]. Briefly, for treatment, cells were incubated in 35-mm
dishes in DMEM (25.5 mM glucose) medium supplemented with
10% fetal bovine serum plus (FBS) at 37uCw i t h5 %C O 2/95%
O2 until 80 to 90% confluence. Isolated islets were cultured
overnight in 10% FBS/RPMI 1640 (11 mM glucose) until
treatment.
After 30 minutes’ preincubation in Met-free DMEM for MIN6
b-cells or Met and/or cysteine-free RPMI 1640 medium for islets,
mouse islets or MIN6 cells were labeled with
35S-Met, and human
islets were labeled with
35S-Met/
35S-Cys in the same media. We
conducted the various chase tests using pre-balanced complete
DMEM/10% FBS media with or without agents. After pulse and/
or chase incubations, islets and MIN6 b-cells were quickly washed
twice with PBS containing 20 mM N-ethylmaleimide and
immediately lysed in the IP buffer and/or frozen at 280uC.
Protein extraction buffers and sample preparations for
immunoblotting and immunoprecipitation
To extract protein, we utilized RIPA, tricine gel sample (Bio-
Rad), and IP buffers [16,29]. The SPP procedures, IP tests, and
protein samples for SDS-PAGE are detailed in the Text S1
Supplemental Experimental Procedures.
SDS-PAGE
We boiled protein samples for 10 minutes in tricine gel sample
buffer with and without 100 mM of DTT for SDS-PAGE.
Tricine-SDS-PAGE gels without urea were applied for all other
tests in this article except the one with urea (Fig. 3A) and the 7.5%
Laemmli SDS-PAGE (Fig. 4D). Gel concentrations (%T, % C; T
denotes the total percentage of concentration of both acrylamide
and bisacrylamide; C denotes the percentage of concentration of
bisacrylamide relative to total concentration) are described in
figure legends.
Immunoblotting and radioautography
We performed immunoblotting following standard procedures
using antibodies against C-peptide or tubulin. For autoradiogra-
phy, we dried membrane and fixed gels with labeled materials for
exposure on x-films.
Quantitative analysis of immunoreactivity and
radioactivity
To quantify the density and radioactivity of protein bands (area
and/or gel slices), we used National Institutes of Health (NIH)
Image J software and/or liquid scintillation counter and gamma
counter (Beckman Coulter, Inc., Brea, CA, USA).
Methods of calculating the proportions of proinsulin or
control protein monomers and non-monomers
In general, the amount of protein monomer(s) in a reduced
SDS-PAGE/membrane (by adding DTT) is accepted as the total
level of protein in loaded samples. Resolution of equal amounts of
protein in individual samples by SDS-PAGE under non-reduced
and reduced conditions permits calculation of the fractions of
protein monomers and non-monomers (referred to as DTT-
sensitive forms) in individual samples. The resolution is possible
because conversion of protein from its DTT-sensitive non-
monomer states to monomers by the effect of DTT yields different
protein monomer levels between the two conditions. We
calculated the proportions of proinsulin or control protein
monomers and non-monomers shown in the following sections
by the formulas: monomers (%)=(monomer level under non-
reduced condition)6100%/(monomer level under reduced condi-
tion); non-monomers (%)=(monomer level under reduced con-
dition2monomer level under non-reduced condition)6100%/
(monomer level under reduced condition); or non-monomers
(%)=100%2monomers (%).
Data analysis
Data are presented as the mean 6 standard deviation (SD; n=3
to 6). We assessed statistical significance (*P,0.05; **P,0.005) by
Student’s t-test (2-tailed) or analysis of variance if appropriate.
Supplemental data
Supplemental data, including Text S1 supplemental experi-
mental procedures, are presented with 3 figures and 15 tables on
the PLoS ONE web site.
Supporting Information
Figure S1 Molecular weights of the clearly resolved
states of insulin precursor shown in figure 1 (A) and the
states of insulin precursor in cloned mouse b-cells (B).
(A) Molecular weights of the well resolved proinsulin states were
calculated by comparing their electrophoretic mobility with those
of the SeeBlueH Plus2 protein markers (Invitrogen). The molecular
weights of the smears can be inferred by the shown molecular
weights of protein markers. (B) Whole-cell proteins of Ins2
+/+,
Ins2
+/Akita, and MIN6 b-cells were extracted directly in the tricine
sample buffer by SPP-B, resolved by tricine-SDS-PAGE without
urea (20%T, 5% C), and then subjected to C-peptide immuno-
blotting analysis.
(TIF)
Figure S2 Completely folded
125I-proinsulin in islet
protein extracts through immunoprecipitation and
electrophoresis does not form significant aggregates.
We added
125I-proinsulin monomer marker (Linco) to the im-
munoprecipitation (IP) buffer and subjected Ins2
+/+ and Ins2
+/Akita
islet proteins extracted in this IP buffer to IP with insulin and
C-peptide antisera. Equal amounts of individual immunoprecip-
itates were resolved by 10% non-reduced and reduced tricine-
SDS-PAGE. Gel radioautograph showed that no significant
aggregation of the
125I-proinsulin itself and/or with islet pro-
teins (e.g., endogenous proinsulin) occurred through the IP and
electrophoresis.
(TIF)
Figure S3 The islet nascent proteins with a small
fraction of non-monomers after 30-min de novo synthe-
sis. Mouse islets were labeled with
35S–Met for 30 minutes, and
cellular proteins were then subjected to IP with antisera against to
the proteins listed above. Equal amounts of individual immuno-
precipitates were resolved by non-reduced and reduced SDS-
PAGE for autoradiography. The monomer and non-monomer
proportions of proteins in immunoprecipitates were calculated
using the method introduced in ‘‘Materials and Methods.’’ The
calculated results indicated that the non-monomer proportions of
the above shown proteins were all less than 20%.
(TIF)
Table S1 Proportions of individual states of insulin
precursor in Figure 1A.
(PDF)
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non-reduced versus reduced condition in Figure 1A.
(PDF)
Table S3 Proportions of proinsulin monomers and non-





Table S4 Proportions of nascent proinsulin monomers
and non-monomers precipitated by insulin (Ins) or C-
peptide (Cp) antisera from mouse islets labeled for
30 minutes.
(PDF)
Table S5 Proportions of nascent proinsulin monomers
and non-monomers precipitated by C-peptide antisera
from Ins2
+/+ and Ins2
+/Akita islets labeled for 45 min-
utes.
(PDF)
Table S6 Proportions of nascent proinsulin monomers
and non-monomers in human islets labeled for 30 min-
utes.
(PDF)




+/Akita islet protein extracts that was subjected
to IP and electrophoresis did not form significant
aggregates.
(PDF)
Table S8 Proportions of proinsulin monomers and
nom-monomers in C-peptide (Cp) or insulin (Ins)
immunoprecipitates obtained from MIN6 b-cells labeled
for 5, 15, or 30 minutes.
(PDF)
Table S9 Proportions of islet amyloid polypeptide
precursor monomers and nom-monomers in MIN6 b-
cells labeled for 5, 15, or 30 minutes.
(PDF)
Table S10 Proportions of nascent proinsulin monomers
and nom-monomers in MIN6 b-cells chased for the
indicated times with/without antimycin, DTT, or GSSG
after a 5-min pulse.
(PDF)
Table S11 Proportions of nascent PC1/3 monomers
and nom-monomers in MIN6 b-cells chased for the
indicated times with/without antimycin, DTT, or GSSG
after a 5-min pulse.
(PDF)
Table S12 Relative levels of nascent proinsulin in MIN6
b-cells chased for the indicated times with/without
antimycin, DTT, or GSSG after a 5-min pulse.
(PDF)
Table S13 Relative levels of nascent PC1/3 in MIN6 b-
cells chased for the indicated times with/without
antimycin, DTT, or GSSG after a 5-min pulse.
(PDF)
Table S14 Proportions of nascent proinsulin monomers
and nom-monomers in MIN6 b-cells chased for the
indicated times with/without antimycin after a 15-min
pulse.
(PDF)
Table S15 Relative levels of nascent proinsulin in MIN6
b-cells chased for the indicated times with/without
antimycin after a 15-min pulse.
(PDF)
Text S1 Supplemental Experimental Procedures.
(DOC)
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